Given the importance of these enzymes, we assessed their expression in CRC cells upon AT-I treatment and found that downregulation of HK2 expression in response to treatment with AT-1 had no discernable effect on PFK or PKM2. This evidence concerns the gene PKM and colorectal carcinoma.